{
  "docId": "019dd923-5ca1-7489-b638-42055a53b541",
  "docSlug": "1774c324fda45105",
  "documentTitle": "Pivoting to a High Quality Growth of Clinical Trials in China PharmaDJ x L.E.K. Clinical Development Report",
  "authorId": "LEK",
  "authorName": "L.E.K.",
  "documentKindSlug": "consulting-deck",
  "documentKindLabel": "Consulting deck",
  "sourceTypeSlug": "strategy_consulting",
  "sourceTypeLabel": "Strategy consulting",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.778,
  "pageNumber": 42,
  "pageCount": 58,
  "prevPage": 41,
  "nextPage": 43,
  "slideType": "testimonial",
  "function": "summarize",
  "density": "dense",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": [
    "headline_text",
    "icon_grid",
    "quote_block"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5ca1-7489-b638-42055a53b541/42",
  "deckHref": "/decks/019dd923-5ca1-7489-b638-42055a53b541",
  "deckJsonHref": "/decks/019dd923-5ca1-7489-b638-42055a53b541.json",
  "deckAnchorHref": "/decks/019dd923-5ca1-7489-b638-42055a53b541#slide-42",
  "components": [
    {
      "bbox": {
        "h": 0.5,
        "w": 0.08,
        "x": 0.037,
        "y": 0.29
      },
      "kind": "image",
      "text": null,
      "attrs": null,
      "subkind": "icon-grid",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ac3c70ec-eab1-4c1c-b6b1-3efd6b123fa3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.275,
        "x": 0.037,
        "y": 0.215
      },
      "kind": "paragraph",
      "text": "Factors considered for oversea clinical trial",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "66330655-7740-4db8-94e1-c7dfe1302b71",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.18,
        "x": 0.13,
        "y": 0.705
      },
      "kind": "quote",
      "text": "Active communication with regulatory agencies",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "618ffee9-f2f9-4a37-8c06-5caff98d310e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.18,
        "x": 0.13,
        "y": 0.325
      },
      "kind": "quote",
      "text": "Careful prioritization of trial destination",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "734c203a-6c17-47a1-850d-ae5ac8f8c625",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.15,
        "x": 0.145,
        "y": 0.515
      },
      "kind": "quote",
      "text": "Oversea local team setup",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "994e378e-089c-4e7f-84d5-c352fd4e8705",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "Companies should prioritize their oversea clinical trial destinations wisely. Factors such as patient base, local regulations, geopolitics, and commercial potential in each destination should be thoroughly considered when designing the ex-China trial road map - CEO & CMO, a Chinese biotech, Nov. 2022",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd951-c7ca-701b-9cbe-ea0e0baaceb5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.2,
        "x": 0.037,
        "y": 0.9
      },
      "kind": "source-note",
      "text": "Source: Yicai, L.E.K. interviews and analysis",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "afdcdcfe-069d-4648-85e6-e863dcb5048d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.045,
        "w": 0.925,
        "x": 0.037,
        "y": 0.06
      },
      "kind": "title",
      "text": "In order to succeed in oversea clinical trial, careful prioritization of destination, oversea local team setup, and active communication with regulatory agencies are anticipated",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "396457d0-58d4-4970-bcf1-de2e81717d85",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.015,
        "w": 0.236,
        "x": 0.037,
        "y": 0.035
      },
      "kind": "title",
      "text": "Globalization of Chinese Biopharma",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "cfb5c5eb-2714-4a29-9feb-ca33fc632c5d",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}